Business StandardCenter·
State scrutiny of pharma price mark-ups may lead to review of TMR policy
Drug regulators in Maharashtra, Karnataka and Uttar Pradesh are gathering data on price mark-ups, potentially strengthening the case for a review of trade margin rationalisation
Read at Business Standard →




